3D Structure Inspector
Structure Overview
Ligand Interactions

4F9W - Overview - 3D Structure Inspector

Atoms
Solvent
Spheres
Surface
Colour
Opacity
Texture
Background

LeftMouse Rotate
Shift+Left Scale
Ctrl+Left Translate
Click Select
+,− Clipping
r Reset view

AstexViewer™ Copyright (C) 1999-2007 Astex Therapeutics Ltd.
OpenAstexViewer Copyright (C) 2007-2014 Mike Hartshorn





Display Compound Structure Het Het Names Het Formula
GG5
GG5
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE
C14 H10 F N3
ACT
ACETATE ION
ACT
ACETATE ION
C2 H3 O2
GOL
CRY
E422
GLYCERIN
GOL
Glycerin
Glycerol
Glycogelatin
Keybells
MONOCTANOIN COMPONENT D
Monoctanoin Component D
Nirolex
Ophthalgan
Optim
Osmoglyn
Procalamine
Senokot Direct Relief
Tixylix Baby
Tixylix Toddler
Waterhouse
GLYCEROL
C3 H8 O3
LM4
LM4
N,N-dimethyl-6-(naphthalen-2-yl)-5-(pyridin-4-yl)p...
C21 H18 N4
ZN
/ZN
ZINC ION
ZN
ZN2
ZINC ION
Zn
PDB Code4F9W
TitleHUMAN P38ALPHA MAPK IN COMPLEX WITH A NOVEL AND SELECTIVE SMALL MOLECULE INHIBITOR
Deposition
Release
Last Modified
ObsoleteNo
ClassificationTRANSFERASE/TRANSFERASE INHIBITOR
Experiment TypeX-RAY DIFFRACTION
Space GroupP 21 21 21
Resol Range High2
Resol Range Low30
Pubmed Id23840427
Doi10.1371/JOURNAL.PONE.0066226
PDB Chain4F9W_A (click to show/hide)